T

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Associate Medical Director - Pharmacovigilance

Biology & BiotechConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$194.4k - $291.6kIn-person

About the Job

Requirements

  • At least 4 years of total relevant experience in pharmacovigilance/drug safety, clinical research, or a related area.
  • MD, DO, foreign medical graduate, or equivalent clinical/medical qualification.
  • Relevant experience in pharmacovigilance, drug safety, or clinical research.
  • Hands-on experience in ICSR medical review and case assessment.
  • A good understanding of ICH, GVP, FDA, EMA, and applicable pharmacovigilance requirements.
  • Working knowledge of WHO drug and MedDRA terminology and coding principles.
  • Strong clinical assessment, analytical, medical writing, and communication skills.
  • Ability to independently assess complex clinical cases and make sound medical judgments.
  • Excellent communication and cross-functional collaboration skills.

Responsibilities

  • Review Individual Case Safety Reports (ICSRs) from clinical trials, literature, solicited programs, and other sources.
  • Assess adverse events for seriousness, causality, expectedness/listedness, and clinical significance in accordance with regulations and company procedures.
  • Evaluate case details for medical consistency, including demographics, history, medications, laboratory results, treatment, course, and outcomes.
  • Review and validate MedDRA coding, diagnoses, events, indications, and relevant medical data.
  • Assess temporal relationships, de-challenge/rechallenge, alternative etiologies, risk factors, and outcomes, as applicable.
  • Review, edit, and approve ICSR narratives for accuracy, completeness, concision, and clinical coherence.
  • Author company comments for ICSRs documenting the medical assessment, clinical rationale, causality considerations, relevant medical history, alternative etiologies, and overall safety evaluation, as applicable.
  • Review queries, identify key missing information, and recommend appropriate case follow-up queries.
  • Ensure proper documentation and escalation of significant safety information.
  • Review vendor-created AOSEs and AOSE search terms for medical accuracy, completeness, consistency, and appropriateness.
  • Escalate medically significant cases and potential safety concerns to appropriate stakeholders.
  • Provide medical guidance to the vendor on findings and recurring quality issues.
  • Monitor quality and consistency and identify trends requiring training or process improvement.
  • Provide vendor guidance and feedback to maintain consistent ICSR quality.
  • Support the creation or maintenance of pharmacovigilance procedures, medical review guidelines, AOSE criteria, training materials, quality metrics, and other relevant activities.
  • Provide medical oversight of vendor-performed ICSR activities.
  • Review vendor deliverables for quality, accuracy, completeness, and timeliness.
  • Identify recurring medical review quality issues and share findings with the vendor.
  • Support vendor training and clarify medical review expectations, as needed.
  • Contribute to vendor performance monitoring and quality improvement.
  • Complete other ad hoc activities as assigned.

Desired Qualifications

  • Two to five years of hands-on ICSR medical review experience is preferred.
  • Experience reviewing AOSEs or other safety surveillance assessments is preferred.

About the Company

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Tango Therapeutics develops cancer medicines by leveraging synthetic lethality to selectively kill cancer cells while sparing healthy cells. Its approach focuses on creating drugs that exploit interactions between gene pairs, aiming for targeted therapies that spare normal tissue. The company advances its treatments through a strong R&D program and collaborates with larger pharmaceutical partners, such as Gilead Sciences, to co-develop therapies and accelerate commercialization. Revenue comes from these partnerships and funding rounds like its Series B. Tango differentiates itself with a dedicated emphasis on genetically targeted cancer therapies, a robust pipeline, and leadership that guides strategic collaborations. The company’s goal is to bring next-generation, genetically targeted immunotherapies to market, improving outcomes for cancer patients by precisely targeting tumor biology.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Tango Therapeutics

See more jobs